Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Eric Klein who wrote (5008)	12/5/1997 12:45:00 PM
From: aknahow	Read Replies (2) \| Respond to of 17367

Eric, I also subscribe to CTSL and was pleased when he included Xoma as one of his picks. In general terms if BPI proves itself as a means of combating resistance to antibiotics I would hink that it would be effective in many different pplications. However, what I find strange is that if the potential is so obvious, why has the market overlooked XOMA? It would seem the market does not believe the potential is as great as I might think. Realize we have gone back and forth on this issue for a long time. I recognize the market is not efficient and that the pricing of stocks like CORR & IDPH changed overnight on events that were obvious to posters on their threads but ignored by the market until further clarified.